X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs NOVARTIS - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH NOVARTIS STERLING BIOTECH/
NOVARTIS
 
P/E (TTM) x -1.7 363.2 - View Chart
P/BV x 0.1 17.9 0.4% View Chart
Dividend Yield % 0.0 1.6 -  

Financials

 STERLING BIOTECH   NOVARTIS
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
NOVARTIS
Mar-16
STERLING BIOTECH/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs11982 1.1%   
Low Rs3556 0.6%   
Sales per share (Unadj.) Rs26.8252.9 10.6%  
Earnings per share (Unadj.) Rs-15.062.1 -24.1%  
Cash flow per share (Unadj.) Rs-5.563.3 -8.6%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs54.9363.6 15.1%  
Shares outstanding (eoy) m267.8731.96 838.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.0 8.5%   
Avg P/E ratio x-0.512.4 -3.8%  
P/CF ratio (eoy) x-1.312.2 -10.5%  
Price / Book Value ratio x0.12.1 6.0%  
Dividend payout %016.1 0.0%   
Avg Mkt Cap Rs m1,86224,580 7.6%   
No. of employees `0001.40.8 180.1%   
Total wages/salary Rs m5471,801 30.4%   
Avg. sales/employee Rs Th5,303.310,748.9 49.3%   
Avg. wages/employee Rs Th403.82,395.2 16.9%   
Avg. net profit/employee Rs Th-2,959.02,641.1 -112.0%   
INCOME DATA
Net Sales Rs m7,1818,083 88.8%  
Other income Rs m43829 5.1%   
Total revenues Rs m7,2238,913 81.0%   
Gross profit Rs m947234 404.3%  
Depreciation Rs m2,54337 6,929.7%   
Interest Rs m4,3772 243,172.2%   
Profit before tax Rs m-5,9311,025 -578.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m017 0.0%   
Extraordinary Inc (Exp) Rs m01,696 0.0%   
Tax Rs m-1,924752 -255.9%   
Profit after tax Rs m-4,0071,986 -201.7%  
Gross profit margin %13.22.9 455.1%  
Effective tax rate %32.473.4 44.2%   
Net profit margin %-55.824.6 -227.1%  
BALANCE SHEET DATA
Current assets Rs m14,33512,678 113.1%   
Current liabilities Rs m49,8092,433 2,047.2%   
Net working cap to sales %-494.0126.7 -389.8%  
Current ratio x0.35.2 5.5%  
Inventory Days Days40333 1,233.8%  
Debtors Days Days17122 758.8%  
Net fixed assets Rs m55,43269 80,104.5%   
Share capital Rs m268160 167.6%   
"Free" reserves Rs m13,93511,460 121.6%   
Net worth Rs m14,70111,621 126.5%   
Long term debt Rs m9,4780-   
Total assets Rs m73,98814,400 513.8%  
Interest coverage x-0.4570.5 -0.1%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.10.6 17.3%   
Return on assets %0.513.8 3.6%  
Return on equity %-27.317.1 -159.5%  
Return on capital %-6.423.6 -27.3%  
Exports to sales %25.90.7 3,477.7%   
Imports to sales %0.218.6 0.9%   
Exports (fob) Rs m1,86060 3,089.4%   
Imports (cif) Rs m121,503 0.8%   
Fx inflow Rs m1,860186 998.3%   
Fx outflow Rs m251,821 1.4%   
Net fx Rs m1,835-1,635 -112.3%   
CASH FLOW
From Operations Rs m1,7192,531 67.9%  
From Investments Rs m-3,148-8,270 38.1%  
From Financial Activity Rs m1,426-386 -369.7%  
Net Cashflow Rs m-3-6,125 0.1%  

Share Holding

Indian Promoters % 33.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 2.0 -  
FIIs % 9.9 1.6 618.8%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 21.5 182.8%  
Shareholders   21,482 41,647 51.6%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   FDC LTD.  BIOCON LTD  UNICHEM LAB  ALEMBIC PHARMA  AJANTA PHARMA  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue to Fall, IT Sector Growth Projections, and Top Stocks in Action(Pre-Open)

On Wednesday, share markets in India opened in green but ended on a weak note. The BSE Sensex closed lower by 71 points to end the day at 33,704.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Feb 20, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS